Bonmarin Isabelle, Belchior Emmanuel, Lévy-Bruhl Daniel
Institut de veille sanitaire, 12 rue du val d'Osne, 94415 Saint Maurice cedex, France.
Vaccine. 2015 Feb 25;33(9):1099-101. doi: 10.1016/j.vaccine.2015.01.023. Epub 2015 Jan 17.
With declining influenza vaccine coverage in the elderly in recent years in France, we aimed at assessing the benefits of seasonal influenza vaccination, based on available data for observed mortality, vaccine coverage and vaccine effectiveness. To estimate the annual number of deaths avoided by vaccination in the people aged 65 years or more, we used the following three elements: an estimate of vaccine effectiveness against all-cause mortality (based on the "difference-in-differences" approach which reduces the usual bias seen in observational studies), French mortality data and vaccine coverage data. We estimated an annual average of 2000 deaths currently avoided through vaccination and a vaccine effectiveness of 35% against influenza-attributable deaths. Around 2650 vaccinations are needed to prevent a death among the elderly. Communicating these results should help restoring at-risk populations' confidence in influenza vaccination.
近年来法国老年人流感疫苗接种率不断下降,我们旨在根据观察到的死亡率、疫苗接种率和疫苗效力的现有数据,评估季节性流感疫苗接种的益处。为了估计65岁及以上人群通过接种疫苗避免的年死亡人数,我们使用了以下三个要素:针对全因死亡率的疫苗效力估计值(基于“差异中的差异”方法,该方法减少了观察性研究中常见的偏差)、法国死亡率数据和疫苗接种率数据。我们估计目前每年通过接种疫苗平均可避免2000例死亡,疫苗对流感所致死亡的效力为35%。大约需要进行2650次接种才能预防一名老年人死亡。传达这些结果应有助于恢复高危人群对流感疫苗接种的信心。